Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Cited by (1,006)

Items 801–900 of 1,006

1. Health-Related Aspects of Beer: A Review
   Sara Sohrabvandi, Amir Mohammad Mortazavian, Karamatollah Rezaei · 2011 · International Journal of Food Properties
2. Mast cells: A double-edged sword in cancer
   Afshin Derakhshani, Fatemeh Vahidian, Mohammad Ali‐Hassanzadeh, Ahad Mokhtarzadeh, Parisa Lotfi Nezhad, Behzad Baradaran · 2019 · Immunology Letters
3. Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children’s Oncology Group
   Leo Mascarenhas, Yueh-Yun Chi, Pooja Hingorani, James Robert Anderson, Elizabeth Ruby Lyden, David Anthony Rodeberg, Daniel Joseph Indelicato, Simon Ching-Shun Kao, Roshni A. Dasgupta, Sheri L. Spunt et al. · 2019 · Journal of Clinical Oncology
4. Epidermal Growth Factor Modulates the Expression of Vascular Endothelial Growth Factor in the Human Prostate
   Neelakanta Ravindranath, Didier Wion, Philippe Brachet, Daniel Djakiew · 2001 · Journal of Andrology
5. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen
   Yu-quan Wei, Mei-juan Huang, Yang Li, Xia Zhao, Ling Tian, You Lü, Jing-mei Shu, Chong-jiu Lu, Ting Niu, Bin Kang et al. · 2001 · Proceedings of the National Academy of Sciences
6. In Vivo Angiogenesis Is Suppressed by Unsaturated Vitamin E, Tocotrienol ,
   Kiyotaka Nakagawa, Akira Shibata, Shinji Yamashita, T. Tsuzuki, Jun Kariya, Shinichi Oikawa, Teruo Miyazawa · 2007 · Journal of Nutrition
7. Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer
   Nimeshi Fernando, Herbert I. Hurwitz · 2003 · Seminars in Oncology
8. Emerging drugs to treat squamous cell carcinomas of the head and neck
   Christopher Fung, Jennifer Rubin Grandis · 2010 · Expert Opinion on Emerging Drugs
9. Cilengitide: An RGD Pentapeptide ανβ3 and ανβ5 Integrin Inhibitor in Development for Glioblastoma and Other Malignancies
   David A. Reardon, Bart Neyns, Michael Weller, J. C. Tonn, Burt Nabors, Roger Stupp · 2011 · Future Oncology
10. Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma
    Lory Santarelli, Elisabetta Strafella, Sara Staffolani, Monica Amati, Monica Emanuelli, Davide Sartini, Valentina Pozzi, Damiano Carbonari, Massimo Bracci, Elettra Pignotti et al. · 2011 · PLoS ONE
11. The Role of Vascular Endothelial Growth Factor (VEGF) in Tumor Angiogenesis and Early Clinical Development of VEGFReceptor Kinase Inhibitors
    Henk M.W. Verheul, Herbert M. Pinedo · 2000 · Clinical Breast Cancer
12. GROWTH FACTORS IN HAIR ORGAN DEVELOPMENT AND THE HAIR GROWTH CYCLE
    Dominik Péus, Mark R. Pittelkow · 1996 · Dermatologic Clinics
13. Pathogenesis of retinopathy of prematurity
    LEH Smith · 2002 · Acta Paediatrica
14. The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis
    Chia‐Jui Weng, Gow‐Chin Yen · 2010 · Clinical & Experimental Metastasis
15. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer
    Dagmar Strohmeyer, Christian R�ssing, Franz Strauss, Anja Bauerfeind, Olaf Kaufmann, Stefan A. Loening · 2000 · The Prostate
16. Incidence and management of bevacizumab-related toxicities in colorectal cancer
    M. W. Saif, Ranee Mehra · 2006 · Expert Opinion on Drug Safety
17. Affinity Improvement of a VEGF Aptamer by in Silico Maturation for a Sensitive VEGF-Detection System
    Yoshihiko Nonaka, Wataru Yoshida, Koichi Abe, Stefano R. Ferri, Holger Schulze, Till T. Bachmann, Kazunori Ikebukuro · 2012 · Analytical Chemistry
18. Angiogenesis in pterygium: Morphometric and immunohistochemical study
    Arie L. Marcovich, Yair Morad, Judith Sandbank, Monica Huszar, Mordechai Rosner, Ayala Pollack, Mehrdad Herbert, Yaron Bar‐Dayan · 2002 · Current Eye Research
19. The function of vascular endothelial growth factor
    Bonnie J. Nieves, Patrìcia A. D'Amore, Brad Allen Bryan · 2009 · BioFactors
20. VEGF and Intraocular Neovascularization: From Discovery to Therapy
    Napoleone Ferrara · 2016 · Translational Vision Science & Technology
21. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Lawrence F. Brown, Kathi Tognazzi, Harold F. Dvorak, Terence J. Harrist · 1996 · Europe PMC (PubMed Central)
22. Engineering therapeutic monoclonal antibodies
    Xiao‐Yun Liu, Laurentiu M. Pop, Ellen S. Vitetta · 2008 · Immunological Reviews
23. Expression of Vascular Endothelial Growth Factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in Postmenopausal Uterine Endometrial Carcinoma
    M. Hirai, Akira Nakagawara, 達也 大崎, Yujiro Hayashi, M. Hirono, T. Yoshihara · 2001 · Gynecologic Oncology
24. Tumor angiogenesis as a therapeutic target
    Alex Matter · 2001 · Drug Discovery Today
25. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase
    Joaquim Marcoval, Abelardo Moreno, Jordi Graells, August Vidal, Josep Maria Escribà, Marta García‐Ramírez, Àngels Fabra · 1997 · Journal of Cutaneous Pathology
26. NF‐κB ‐inducing kinase is a key regulator of inflammation‐induced and tumour‐associated angiogenesis
    Ae R Noort, K P M van Zoest, Ester M. Weijers, Pieter Koolwijk, Chrissta X. Maracle, Deborah V. Novack, Martin J. Siemerink, Reinier O. Schlingemann, Paul Peter Tak, Sander W. Tas · 2014 · The Journal of Pathology
27. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
    Adrian M. Jubb, Helen Turley, Hugo C. Moeller, Graham Steers, C Han, JL Li, Russell Leek, Ern Yu Tan, Baljit Singh, Neil Mortensen et al. · 2009 · British Journal of Cancer
28. Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies
    Hans‐Peter Gerber, Xiumin Wu, Lanlan Yu, Christian Wiesmann, Xiao Huan Liang, Chingwei V. Lee, Germaine Fuh, Christine Olsson, Lisa A. Damico, David Xie et al. · 2007 · Proceedings of the National Academy of Sciences
29. Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting,during a critical developmental period
    Gavin Thurston, Quan Wang, Fabienne Baffert, John S. Rudge, Nicholas J. Papadopoulos, Danielle Jean-Guillaume, Stanley J. Wiegand, George D. Yancopoulos, Donald M. McDonald · 2005 · Development
30. Bevacizumab in the Treatment of Breast Cancer: Rationale and Current Data
    Hope S. Rugo · 2004 · The Oncologist
31. Olive oil, other seasoning fats, and the risk of colorectal carcinoma
    Cláudia Braga, Carlo La Vecchia, Silvia Franceschi, Eva Negri, Maria Teresa Parpinel, Adriano Decarli, Attilio Giacosa, Dimitrios Trichopoulos · 1998 · Cancer
32. Bevacizumab
    Paul L. McCormack, Susan J. Keam · 2008 · Drugs
33. Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy
    Jing‐biao Wu, Ya‐ling Tang, Xin‐hua Liang · 2018 · OncoTargets and Therapy
34. Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
    Paola Ciciola, Priscilla Cascetta, Cataldo Bianco, Luigi Formisano, Roberto Bianco · 2020 · Journal of Clinical Medicine
35. Contrast‐Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma
    Laura J. Esserman, Nola M. Hylton, Tracy I. George, Noel Weidner · 1999 · The Breast Journal
36. Monoclonal Antibodies to Vascular Endothelial Growth Factor (VEGF) And the VEGF Receptor, FLT-1, Inhibit the Growth of C6 Glioma in a Mouse Xenograft
    David F. Stefanik, Wendy K. Fellows, Laila R. Rizkalla, Waheeb M. Rizkalla, Paulette P. Stefanik, Albert B. DeLeo, William Charles Welch · 2001 · Journal of Neuro-Oncology
37. Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination
    Analisa V. DiFeo, Goutham Narla, Jennifer Hirshfeld, Olga Camacho‐Vanegas, Jyothsna Narla, Stephen L. Rose, Tamara Kalir, Shen Yao, Alice C. Levine, Michael J. Birrer et al. · 2006 · Clinical Cancer Research
38. Anti-Flt1 Peptide, a Vascular Endothelial Growth Factor Receptor 1–Specific Hexapeptide, Inhibits Tumor Growth and Metastasis
    Donggoo Bae, Tae‐Dong Kim, Ge Li, Wan-Hee Yoon, Chi‐Bom Chae · 2005 · Clinical Cancer Research
39. True
    Shingo Takano, K. Tsuboi, Y Tomono, Tadao Nose, Youji Mitsui · 2000 · British Journal of Cancer
40. Cancer nanotheranostics: A review of the role of conjugated ligands for overexpressed receptors
    Lydia Ramzy, Maha Nasr, Abdelkader A. Metwally, Gehanne A.S. Awad · 2017 · European Journal of Pharmaceutical Sciences
41. E7050: A dual c‐Met and VEGFR‐2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models
    Takayuki Nakagawa, Osamu Tohyama, Atsumi Yamaguchi, Tomohiro Matsushima, Keiko Takahashi, Setsuo Funasaka, Shuji Shirotori, Makoto Asada, Hiroshi Obaishi · 2009 · Cancer Science
42. Therapeutic Use of Heparin beyond Anticoagulation
    Ralf Joachim Ludwig · 2009 · Current Drug Discovery Technologies
43. Expression of Vascular Endothelial Growth Factor in Canine Mammary Tumors
    Brunella Restucci, Serenella Papparella, Paola Maiolino, Gionata De Vico · 2002 · Veterinary Pathology
44. Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma
    Gassimou Bangoura · 2007 · World Journal of Gastroenterology
45. Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas.
    Lilyana Angelov, Bodour Salhia, Luba Roncari, Gerald McMahon, Abhijit Guha · 1999 · PubMed
46. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model
    Frank Griscelli, Hong Li, Chiat Cheong, Paule Opolon, Annelise Bennaceur Griscelli, Gilles Vassal, J. Soria, Claudine Soria, Lu H, Michel Perricaudet et al. · 2000 · Proceedings of the National Academy of Sciences
47. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells.
    Naresh Arora, R. Masood, Tong Zhang Zheng, Jie Cai, Diane Lynne Smith, Parkash S. Gill · 1999 · PubMed
48. Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer
    Thomas Winder, Heinz‐Josef Lenz · 2010 · Gastroenterology
49. Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
    Mallika Singh, Napoleone Ferrara · 2012 · Nature Biotechnology
50. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix
    Kimberly L. Dumoff, Christina Chu, Xiaowei Xu, Theresa L. Pasha, Paul J. Zhang, Géza Ács · 2004 · Modern Pathology
51. Thy-1, a Novel Marker for Angiogenesis Upregulated by Inflammatory Cytokines
    Wen Sen Lee, Mukesh K. Jain, Burak M. Arkonac, Dorothy Zhang, Shyh‐Yu Shaw, Saori Kashiki, Koji Maemura, Shwu-Luan Lee, Norman K. Hollenberg, Mu-En Lee et al. · 1998 · Circulation Research
52. Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization
    An Claes, Pieter Wesseling, Judith W. M. Jeuken, Cathy Maass, Arend Heerschap, William P. J. Leenders · 2008 · Molecular Cancer Therapeutics
53. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer.
    William D. Fox, Brian Higgins, Krista Maiese, Marija Drobnjak, Carlos Cordon‐Cardo, Howard I. Scher, David B. Agus · 2002 · PubMed
54. Evaluation of Contrast-Enhanced Color Doppler Ultrasound for the Quantification of Angiogenesis In Vivo
    Nathalie Lassau, Serge Koscielny, Paule Opolon, Thierry de Baère, PIERRE PERONNEAU, J. Leclère, AND ALAIN ROCHE · 2001 · Investigative Radiology
55. Inhibition of Angiogenesis by Adenovirus-Mediated sFlt-1 Expression in a Rat Model of Corneal Neovascularization
    Chooi‐May Lai, Meliha Brankov, Tammy Zaknich, Yvonne K. Y. Lai, Weiyong Shen, Ian Jeffery Constable, Imre Kovesdi, Piroska Elizabeth Rakoczy · 2001 · Human Gene Therapy
56. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
    Z Zhu, Patricia Rockwell, Dan Lu, Helen Kotanides, Bronislaw Pytowski, Daniel J. Hicklin, Peter Böhlen, L Witte · 1998 · PubMed
57. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies
    William T. Bellamy · 2001 · Seminars in Oncology
58. Angiozyme: A Novel angiogenesis inhibitor
    David Edward Weng, Nassim Usman · 2001 · Current Oncology Reports
59. MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α
    Haitao Xu, Liang Zhao, Qiuju Fang, Jianmin Sun, Songyan Zhang, Chao Zhan, Shujie Liu, Yubao Zhang · 2014 · PLoS ONE
60. ALK1 signaling in development and disease: new paradigms
    Beth L. Roman, Andrew P. Hinck · 2017 · Cellular and Molecular Life Sciences
61. Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
    Yuanbo Kang, Weihan He, Caiping Ren, Jincheng Qiao, Qiuyong Guo, Jingyu Hu, Hongjuan Xu, Xingjun Jiang, Lei Wang · 2020 · Signal Transduction and Targeted Therapy
62. A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model
    Wei Zhang, Sophia Ran, Maria J. Sambade, Xianming Huang, Philip E. Thorpe · 2002 · Angiogenesis
63. The cancer stem cell paradigm: a new understanding of tumor development and treatment
    Johnathan D. Ebben, Daniel M. Treisman, Michael Zorniak, Raman G. Kutty, Paul A. Clark, John S. Kuo · 2010 · Expert Opinion on Therapeutic Targets
64. Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma
    Jia Ruan, Katherine A. Hajjar, Shahin Rafii, John Paul Leonard · 2008 · Annals of Oncology
65. Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/ protein and vascular endothelial growth factor
    Mark Daniel Pegram, D Reese · 2002 · Seminars in Oncology
66. Vascular Endothelial Growth Factor-Mediated Autocrine Stimulation of Prostate Tumor Cells Coincides with Progression to a Malignant Phenotype
    Shay Söker, Martin A. Kaefer, Michelle Johnson, Michael Klagsbrun, Anthony Atala, Michael R. Freeman · 2001 · American Journal Of Pathology
67. Androgens Induce the Expression of Vascular Endothelial Growth Factor in Human Fetal Prostatic Fibroblasts**This work was supported by grants-in-aid from the T. J. Martell Foundation for Leukemia, Cancer, and Aids Research; and the Hans E. Schapira, M.D., Foundation for Urologic Research.
    Alice C. Levine, Xinhua Liu, Pietra Dale Greenberg, Mark Eliashvili, Jonathan D. Schiff, Stuart A. Aaronson, James F. Holland, Alexander M. Kirschenbaum · 1998 · Endocrinology
68. Gene Therapy for Brain Tumors
    C. Kramm, M. Sena-Esteves, F. H. Barnett, N. G. Rainov, Deborah E. Schuback, John S. Yu, Peter A. Pechan, W. Paulus, E. Chiocca, X. Breakefield · 1995 · Brain Pathology
69. The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer
    Wan · 2010 · Oncology Reports
70. Current status of angiogenesis inhibitors combined with radiation therapy
    Carsten Nieder, Nicole E. Wiedenmann, Nicolaus H. Andratschke, M. Molls · 2006 · Cancer Treatment Reviews
71. Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer
    Krishnansu S. Tewari, Bradley J. Monk · 2005 · Current Oncology Reports
72. Plasma Vascular Endothelial Growth Factor Concentrations in Healthy Dogs and Dogs with Hemangiosarcoma
    Craig A. Clifford, Dez Hughes, Matthew W. Beal, Andrew J. Mackin, Carolyn J. Henry, Frances Susan Shofer, Karin U. Sørenmo · 2001 · Journal of Veterinary Internal Medicine
73. Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors
    Jean-Marc Schlaeppi, Jeanette Marjorie Wood · 1999 · Cancer and Metastasis Reviews
74. Angiogenesis in Malignancies of the Female Genital Tract
    Ovadia Abulafia, William E. Triest, David M. Sherer · 1999 · Gynecologic Oncology
75. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia‐inducible factor‐1 and the down‐regulation of VEGF gene expression
    Peter Büchler, Howard A. Reber, Markus Wolfgang Büchler, Helmut Frieß, Robert S. Lavey, Oscar Joe Hines · 2003 · Cancer
76. Renal cell carcinoma: Current status and emerging therapies
    Eric C. Nelson, Christopher P. Evans, Primo N. Lara · 2007 · Cancer Treatment Reviews
77. Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis
    Gustav J. Strijkers, Ewelina Kluza, Geralda A. F. van Tilborg, Daisy W.J. van der Schaft, Arjan W. Griffioen, Willem J. M. Mulder, Klaas Nicolay · 2010 · Angiogenesis
78. Unfolded Protein Response Is Required in nu/nu Mice Microvasculature for Treating Breast Tumor with Tunicamycin
    Aditi Banerjee, Jing-Yu Lang, Mien‐Chie Hung, K. Sengupta, Sushanta K. Banerjee, Krishna Baksi, Dipak Kumar Banerjee · 2011 · Journal of Biological Chemistry
79. Herbal melanin modulates tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) production
    Adila El‐Obeid, Sayer Al-harbi, Naif A. Al-Jomah, A. M. Hassib · 2005 · Phytomedicine
80. Vascular Remodeling Marks Tumors That Recur During Chronic Suppression of Angiogenesis
    Jianzhong Huang, Samuel Z. Soffer, Eugene S. Kim, Kimberly W. McCrudden, Joe T. Huang, Tamara N. New, Christina A. Manley, William Middlesworth, Kathleen O’Toole, Darrell J. Yamashiro et al. · 2004 · Molecular Cancer Research
81. Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models
    Ansgar Santel, Manuela Aleku, Nadine Röder, Kristin Möpert, Birgit Durieux, Oliver Janke, Oliver Keil, Jens Endruschat, Sibylle Dames, Christian M. Lange et al. · 2010 · Clinical Cancer Research
82. Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations
    Andy J.G. Pötgens, Nicolette H. Lubsen, Margarethe C. van Altena, Robin Jeanna Vermeulen, Aron F.H.A. Bakker, J.G.G. Schoenmakers, D. J. Ruiter, Robert M.W. de Waal · 1994 · Journal of Biological Chemistry
83. Vascular Endothelial Growth Factor Tightly Regulates In Vivo Development of Murine Hepatocellular Carcinoma Cells
    Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, Masaharu Yamazaki, Masaji Kikukawa, Hirohisa Tsujinoue, Toshiya Nakatani, Hiroshi Fukui · 1998 · Hepatology
84. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma
    Bernhard Meister, Frank Grünebach, Frank Bautz, Wolfram Brugger, Franz Martin Fink, Lothar Kanz, Robert Möhle · 1999 · European Journal of Cancer
85. Fas/Fas Ligand Interaction in Human Colorectal Hepatic Metastases
    Khong F. Yoong, Simon C. Afford, Satinder Randhawa, Stefan G. Hübscher, David Adams · 1999 · American Journal Of Pathology
86. Vascular Endothelial Growth Factor and the Angiopoietins
    Kevin G. Peters · 1998 · Circulation Research
87. Bevacizumab: overview of the literature
    Maria Ignez Braghiroli, Jorge Sabbaga, Paulo M. Hoff · 2012 · Expert Review of Anticancer Therapy
88. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells
    Katsuhiko Takenaka, Sho‐ichi Yamagishi, Yuko Jinnouchi, Kazuo Nakamura, Takanori Matsui, Tsutomu Imaizumi · 2005 · Life Sciences
89. Thromboxane A 2 Receptor Signaling Inhibits Vascular Endothelial Growth Factor–Induced Endothelial Cell Differentiation and Migration
    Anthony W. Ashton, J. Anthony Ware · 2004 · Circulation Research
90. Cerebral arteriovenous malformations. Part 1: cellular and molecular biology
    Parham Moftakhar, Jason Scott Hauptman, Dennis R. Malkasian, Neil Alfred Martin · 2009 · Neurosurgical FOCUS
91. Factors Promoting Tumor Angiogenesis
    Marie E. Beckner · 1999 · Cancer Investigation
92. Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells
    Rolf Mentlein, Olaf Eichler, Frauke Forstreuter, Janka Held‐Feindt · 2001 · International Journal of Cancer
93. Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 Diabetes
    Hussam Al‐Kateb, Lucia Mirea, Xinlei Xie, Lei Sun, Xiaoqing Liu, Hongtao Chen, Shelley B. Bull, Andrew P. Boright, Andrew D. Paterson · 2007 · Diabetes
94. MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers
    Ki‐Seok Jang, Seung Sam Paik, Heekyoung Chung, Young‐Ha Oh, Gu Kong · 2006 · Cancer Science
95. Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement
    Joseph Patrick Erinjeri, Abigail Fong, Nancy E. Kemeny, Karen T. Brown, George I. Getrajdman, Stephen Barnett Solomon · 2010 · Cancer
96. Monitoring Response to Antiangiogenic Therapy in Non–Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI
    Adrianus Johannes de Langen, Vivian van den Boogaart, Mark Lubberink, Walter H. Backes, Johannes Tim Marcus, Harm van Tinteren, Jan Pruim, Boudewijn T. Brans, Pieter Leffers, Anne‐Marie C. Dingemans et al. · 2010 · Journal of Nuclear Medicine
97. pH-Sensitive Chitosan–Heparin Nanoparticles for Effective Delivery of Genetic Drugs into Epithelial Cells
    Iuliia Pilipenko, Viktor A. Korzhikov-Vlakh, Vladimir V. Sharoyko, Nan Zhang, Monika Schäfer‐Korting, Eckart Rühl, Christian Zoschke, Tatiana B. Tennikova · 2019 · Pharmaceutics
98. PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
    Ahmad Aljada, Laura O’Connor, Yu-Yen Fu, Shaker A. Mousa · 2008 · Angiogenesis
99. RETRACTED ARTICLE: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis
    Niranjan Yanamandra, Krishna V Gumidyala, Kevin G Waldron, Meena Gujrati, William C. Olivero, Dzung H. Dinh, Jasti Sambasiva Rao, Sanjeeva Mohanam · 2004 · Oncogene · Retracted
100. Inhibition of Angiogenesis by Humulone, a Bitter Acid from Beer Hop
     Mariko Shimamura, Tadahiko Hazato, Hiromi Ashino, Yukio Yamamoto, Eri Iwasaki, Hiroyasu Tobe, Kei Yamamoto, Shozo Yamamoto · 2001 · Biochemical and Biophysical Research Communications